Recombinant Human CD-25
Cat.No. : | CDA085P |
Product Overview : | Recombinant Human full length CD-25 protein expressed in E.coli.,53 kDa. |
- Specification
- Gene Information
- Related Products
Cat. No. : | CDA085P |
Description : | IL-2R (T-cell growth factor receptor) consists of a chain of 55kDa (also known as Tac antigen or p55 or alpha chain) and a p75 or Beta chain. IL-2Ralpha is over-expressed on the surface of activated T-cells, HTLV-1 or -2 positive T-cell lines, and moderately expressed on activated B-cells, NK-cells, and macrophages. |
Source : | E.coli. |
Presentation : | Recombinant Human CD-25 protein at 100µg/ml in 50mM Tris-Acetate, pH7.5, 1mM EDTA and 20% Glycerol. |
Applications : | •ELISA•Inhibition Assays •Western Blotting |
Characterization : | On SDS-PAGE commassie blue stained gel, the purified recombinant protein shows a band at 53 kDa. |
Storage : | Store vial at -20°Cto -80°C. When stored at the recommended temperature, this protein is stable for 12 months. |
Synonyms : | CD25; IDDM10; IL-2-RA; IL2-RA; IL2R; OTTHUMP00000019030; OTTHUMP00000044870; TCGFR; p55; CD25 antigen; IL-2 receptor alpha subunit; Interleukin-2 receptor; TAC antigen; interleukin 2 receptor, alpha; interleukin 2 receptor, alpha chain. |
Synonyms : | CD25; IDDM10; IL-2-RA; IL2-RA; IL2R; OTTHUMP00000019030; OTTHUMP00000044870; TCGFR; p55; CD25 antigen; IL-2 receptor alpha subunit; Interleukin-2 receptor; TAC antigen; interleukin 2 receptor, alpha; interleukin 2 receptor, alpha chain. |
Products Types
◆ Recombinant Protein | ||
IL2RA-4C | Recombinant Canine IL2RA Protein, His (Fc)-Avi-tagged | +Inquiry |
Il2ra-5704M | Active Recombinant Mouse Il2ra protein(Met1-Lys236), hFc-tagged | +Inquiry |
IL2RA-43H | Recombinant Human IL2RA Protein, C-Avi&His tagged, Biotinylated | +Inquiry |
IL2RA-179I | Active Recombinant Human IL2RA Protein (205 aa), His-tagged | +Inquiry |
IL2RA-320H | Recombinant Human IL2RA Protein, Fc-tagged | +Inquiry |
◆ Lysates | ||
IL2RA-2024MCL | Recombinant Mouse IL2RA cell lysate | +Inquiry |
IL2RA-1015CCL | Recombinant Cynomolgus IL2RA cell lysate | +Inquiry |
IL2RA-2907HCL | Recombinant Human IL2RA cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe combination of IL2RA and other drugs may produce nausea, vomiting, rash and other adverse reactions, should be monitored.
The frequency of use of IL2RA depends on the specific situation of the patient, and is generally used 1-3 times per week.
IL2RA, in the right dosage and frequency of use, can significantly relieve symptoms of diseases such as autoimmune diseases and organ transplant rejection.
Can assist in the treatment of some types of malignant tumors, but it is not a complete cure for cancer.
The effective rate of IL2RA therapy depends on many factors such as the type of disease, the patient's condition and the treatment regimen, and the effective rate is generally between 50% and 90%.
Indications of IL2RA include a variety of autoimmune diseases, organ transplant rejection and malignant tumors.
Customer Reviews (3)
Write a reviewSecurity is very high and can be used with confidence.
Structure is very stable and not prone to mutation.
The amount of expression is very high and can be easily detected.
Ask a Question for All IL2RA Products
Required fields are marked with *
My Review for All IL2RA Products
Required fields are marked with *
Inquiry Basket